Literature DB >> 17121787

Potential role of active vitamin D in retarding the progression of chronic kidney disease.

Jin Tian, Youhua Liu, Laura A Williams, Dick de Zeeuw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17121787     DOI： 10.1093/ndt/gfl595

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  22 in total

1.  Hypovitaminosis D, neighborhood poverty, and progression of chronic kidney disease in disadvantaged populations.

Authors:  R Mehrotra; K Norris
Journal:  Clin Nephrol       Date:  2010-11       Impact factor: 0.975

2.  Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism.

Authors:  Xiaoxin X Wang; Tao Jiang; Yan Shen; Hannah Santamaria; Nathaniel Solis; Cynthia Arbeeny; Moshe Levi
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-05

3.  Prevalence of 25-hydroxyvitamin D deficiency in Korean patients with anemia.

Authors:  Eun-Hyung Yoo; Hyun-Jung Cho
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

4.  Isotretinoin effect on alveolar repair after exodontia--a study in rats.

Authors:  Roberta Dalmolin Bergoli; Otacilio Luiz Chagas Junior; Carlos Eduardo Chrzanowski Pereira de Souza; Beatriz Farias Vogt; Henrique Telles Ramos de Oliveira; Adriana Etges; Daniela Nascimento Silva
Journal:  Oral Maxillofac Surg       Date:  2010-07-25

Review 5.  Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes.

Authors:  Claudio Ronco; Mario Cozzolino
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

6.  Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling.

Authors:  Xiaoyue Tan; Xiaoyan Wen; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2008-06-04       Impact factor: 10.121

Review 7.  Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.

Authors:  Dennis Andress
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells.

Authors:  Jorge N Artaza; Keith C Norris
Journal:  J Endocrinol       Date:  2008-11-26       Impact factor: 4.286

9.  Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Rupal Mehta; Xuan Cai; Jungwha Lee; Dawei Xie; Xue Wang; Julia Scialla; Amanda H Anderson; Jon Taliercio; Mirela Dobre; Jing Chen; Michael Fischer; Mary Leonard; James Lash; Chi-Yuan Hsu; Ian H de Boer; Harold I Feldman; Myles Wolf; Tamara Isakova
Journal:  Am J Kidney Dis       Date:  2019-12-19       Impact factor: 8.860

10.  Effects of vitamin D on kidney histology and trpv1 channels in doxorubicin-induced nephropathy.

Authors:  Ali Gurel; Hasan Atli; Nalan Kaya; Ebru Onalan; Tuncay Kuloglu; Bilge Aygen
Journal:  Int J Clin Exp Med       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.